KZR-8834
- Generic Name
- KZR-8834
KZR-261 in Subjects With Advanced Solid Malignancies
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Kezar Life Sciences, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT05047536
- Locations
- 🇺🇸
START (South Texas Accelerated Research Therapeutics), San Antonio, Texas, United States
🇺🇸Fred Hutchinson Cancer Center, Seattle, Washington, United States
🇺🇸Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath